Archives
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-14
A 2024 Cellular & Molecular Immunology study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing in activated CD8+ T cells. By favoring PKM2 over PKM1 independently of the canonical CD28–PI3K pathway, this mechanism links RNA processing to metabolic flexibility, interferon-γ production, and antitumor immunity.
Trichostatin A (TSA): A Translational Playbook
2026-08-13
Trichostatin A (TSA) is more than a histone deacetylase inhibitor: it is a reversible perturbation tool for connecting chromatin state, tumor-cell behavior, combination response, and in vivo validation. This thought-leadership guide explains how to use TSA strategically in cancer research, with emphasis on epigenetic regulation in cancer, cell-cycle control, and translational decision-making.
DDM for Cryo-EM Membrane Protein Assays
2026-08-13
Discover how n-Dodecyl-β-D-maltoside and DDM can be treated as assay-design variables rather than generic extraction reagents. This guide connects detergent chemistry with cryo-EM analysis of dynamic membrane protein complexes, including full-length αvβ3 integrin.
Bovine Insulin as a Metabolic Control Reagent
2026-08-12
Bovine insulin can do more than support cultured-cell growth: it can define the metabolic baseline against which ROS, PDH phosphorylation, and drug response are interpreted. This article connects insulin from bovine pancreas with rigorous assay design informed by melanoma metabolism research.
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-08-12
This Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a causal target of selective magnetic stimulation in mice. By combining targeted c-MSST, genetic knockdown, conditional knock-in, behavioral testing, synaptic analysis, and molecular assays, the researchers connect GABRE regulation with the reversal of schizophrenia-like phenotypes.
n-Dodecyl-β-D-maltoside in Assay Workflows
2026-08-11
A scenario-driven guide to using n-Dodecyl-β-D-maltoside (SKU C4421) in membrane-protein purification and cell-based assay workflows. It explains how DDM affects solubilization, viability readouts, protocol controls, and vendor selection without assuming that a membrane-protein detergent is biologically inert.
From Reporter Signal to Translational mRNA Design
2026-08-11
A thought-leadership guide to using chemically optimized Firefly Luciferase mRNA as a controlled readout for delivery, translation, and carrier biology. The article connects cap and nucleotide engineering with recent rhamnolipid-stabilized nanovaccine research while defining the limits of reporter-based translational inference.
Eicosapentaenoic Acid: Applied Lab Workflows
2026-08-10
Build reproducible EPA experiments for membrane remodeling, lipoprotein oxidation, endothelial migration, and cardiovascular disease research. This workflow separates low-micromolar lipid assays from higher-dose cellular studies while translating an emerging arachidonic-acid immunology study into carefully bounded assay ideas.
Phosphatase Inhibitor Cocktail 1 in Epigenetic Assays
2026-08-09
Phosphatase Inhibitor Cocktail 1 supports protein phosphorylation preservation during lysis and downstream signaling assays. This guide shows how to integrate it into epigenetic oncology workflows without confusing phosphatase control with evidence of pathway causality.
Mycobacterium tuberculosis WecA: Kinetic Study
2026-08-08
This 2026 study establishes a controlled heterologous-expression and purification strategy for Mycobacterium tuberculosis WecA, an 11-transmembrane enzyme involved in mycobacterial cell-wall assembly. By combining affinity purification, mass-spectrometric identification, UMP-based activity detection, and inhibition analysis, the work creates a practical platform for studying WecA catalysis and anti-tuberculosis inhibitor development.
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-08-07
Oligo (dT) 25 Beads provide a magnetic route for isolating polyadenylated eukaryotic mRNA from total RNA or compatible animal and plant samples. They are appropriate for polyA-selected mRNA workflows, but not for unbiased total RNA recovery or transcripts that lack an accessible polyA tail.
Caspase-6–Mediated N Protein Cleavage Drives PRRSV Immune Ev
2026-08-07
This study reveals that PRRSV enhances its replication by co-opting host caspase-6 to cleave its nucleocapsid protein at a conserved site, suppressing interferon signaling and facilitating immune evasion. Targeting the caspase-6–N protein interaction emerges as a promising route for antiviral and vaccine development.
Calpain Inhibitor I, ALLN: Technical Application Guidance
2026-08-06
Calpain Inhibitor I, ALLN provides selective, potent inhibition of calpain and cathepsin proteases, supporting apoptosis assays and ischemia-reperfusion injury models. It is not suitable for diagnostic or therapeutic use and requires strict adherence to solubility and storage protocols for reliable results.
Diethylmaleate: Optimizing Redox and Toxicology Workflows in
2026-08-06
Diethylmaleate unlocks precise control of intracellular glutathione, empowering advanced oxidative stress and pesticide resistance studies. Its validated use as a GST inhibitor enables breakthroughs in redox modulation and toxicology research, as demonstrated in cutting-edge insecticide resistance models.
Improving In Vitro Drug Response Evaluation in Cancer Resear
2026-08-05
Schwartz's dissertation advances in vitro drug response evaluation by distinguishing the unique contributions of proliferation arrest and cell death in anti-cancer drug assays. This work provides a more nuanced framework for interpreting viability measurements, with practical implications for optimizing the use of HDAC inhibitors like Vorinostat in cancer biology research.
612 records 12/41 page Previous Next First page 上5页 1112131415 下5页 Last page